Factors Influencing Creatine Kinase-MM Concentrations in Newborns and Implications for Newborn Screening for Duchenne Muscular Dystrophy
Overview
Authors
Affiliations
Introduction: Newborn screening for Duchenne muscular dystrophy can be performed via a first-tier creatine kinase-MM measurement followed by reflex testing to second-tier molecular analysis of the DMD gene. In order to establish appropriate cut-offs for the creatine kinase-MM screen, factors that influence creatine kinase-MM in newborns were investigated.
Materials And Methods: Creatine kinase-MM data from a consented pilot study in New York State were collected over a two-year period and combined with de-identified validation data and analyzed. Univariate analysis and multiple linear regression analysis were performed.
Results: The analysis indicated that age of newborn at specimen collection, gestational age and birth weight were significant influencers of CK-MM levels in newborns. In addition, to a lesser extent, sex, race/ethnicity and seasonal temperature also affect CK-MM levels in newborns.
Conclusions: To reduce false positive and false negative cases, newborn screening programs should be cognizant of factors that influence CK-MM when determining cut-offs for the assay. Variability based on age at specimen collection and birth weight are primarily observed within the first week of life. Therefore, particularly during this time period, multi-tiered cut-offs based on age of collection and lower cut-offs for premature and low birth weight babies are recommended. Other cut-off determinants may include sex, race/ethnicity and seasonal temperature.
Potter S, Migliore B, Carter J, Copeland V, Smith E, Peay H Int J Neonatal Screen. 2024; 10(2).
PMID: 38920848 PMC: 11203585. DOI: 10.3390/ijns10020041.
Therrell B, Padilla C, Borrajo G, Khneisser I, Schielen P, Knight-Madden J Int J Neonatal Screen. 2024; 10(2).
PMID: 38920845 PMC: 11203842. DOI: 10.3390/ijns10020038.
Clinical Scoring Tool for Diagnosis of Dystrophinopathies: Can the Tool Finish the Job?.
Hiew F Ann Indian Acad Neurol. 2024; 27(2):118-119.
PMID: 38751931 PMC: 11093167. DOI: 10.4103/aian.aian_682_23.